Drug News

Added 18 hours ago Drug news

New data from Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the HeartLogic Heart Failure Diagnostic to predict impending heart failure (HF) decompensation.- Boston Scientific.

Boston Scientific announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) study evaluating the performance...

Added 18 hours ago Drug news

FDA approves triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), as Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with COPD.-GSK + Innoviva.

GlaxoSmithKline plc and Innoviva, Inc. announced that the FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under...

Added 1 day ago Drug news

Teva sells ParaGard, an intrauterine copper contraceptive device to Cooper Companies for $1.1 billion.

The Cooper Companies has agreed to buy ParaGard, an intrauterine copper contraceptive brand from Teva Pharmaceutical Industries for $1.1 billion...

Added 1 day ago Drug news

Phase III LEAP 1 trial of BC 3781 (lefamulin) meets primary endpoint in community-acquired bacterial pneumonia.- Nabriva Therapeutics.

Nabriva Therapeutics announced positive topline results from the BC 3781 (lefamulin) evaluation against pneumonia (LEAP 1) trial, which evaluated the...

Added 1 day ago Drug news

FDA approves Solosec (secnidazole) for treatment of bacterial vaginosis.- Symbiomix Therapeutics.

Symbiomix Therapeutics announced the FDA has approved Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in...

Added 1 day ago Drug news

CHMP recommends VeraSeal for use as a sealant during surgical operations in adults,- Instituto Grifols.

The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation...

Added 1 day ago Drug news

Baxter International Inc.has announced the publication of "Fish Oil Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the Evidence" in the Journal of Parenteral and Enteral Nutrition.

Baxter International Inc.has announced the publication of "Fish Oil Containing Lipid Emulsions in Adult Parenteral Nutrition: A Review of the...

Added 1 day ago Drug news

Phase III MURANO study of Venclexta (venetoclax) plus Rituxan (rituximab) in relapsed or refractory chronic lymphocytic leukaemia meets primary endpoint.- Genentech/Roche.

Genentech/Roche Group announced that the Phase III MURANO study, which evaluated Venclexta (venetoclax) in combination with Rituxan (rituximab) in people...

Added 1 day ago Drug news

The FDA has accepted for review a Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF) referencing Neupogen (filgrastim).- Adello Biologics.

Adello Biologics announced that FDA has accepted for review the company’s Biologics License Application (BLA) for a biosimilar candidate (TPI-G-CSF)...

Added 1 day ago Drug news

CHMP recommends Cyltezo (adalimumab biosimilar) to treat multiple chronic inflammatory diseases based on clinical equivalence to Humira (adalimumab), the reference product.- Boehringer.

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Search all news articles